Riferimento farmaci
Avatrombopag
Avatrombopag is a medicine in the class miscellaneous. It is used for thrombocytopenia.
- Classe del farmaco: Miscellaneous
- Indicato per: thrombocytopenia
Ultimo aggiornamento Fonti: EMA SmPC, US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Miscellaneous
- Forme farmaceutiche comuni
- compressa
- Dosaggi comuni
- 20 mg, 10 mg
- Interazioni note
- 12 (Moderata: 11 · Minore: 1)
- Nomi commerciali
- 4
- Paesi e mercati
- 3
Per cosa si usa
Come agisce
Orally bioavailable small molecule TPO receptor agonist that stimulates proliferation and differentiation of megakaryocytes from bone marrow progenitor cells, increasing platelet production. It does not compete with TPO for receptor binding and has an additive effect with TPO.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Thrombocytopenia in chronic liver disease before a procedure (tablets): platelet count less than 40×10 9 /L: 60 mg (3 tablets) orally once daily for 5 days, starting 10 to 13 days before the procedure
Gravidanza e allattamento
- Gravidanza
- Unknown Animal studies showed miscarriage in rabbits and pup deaths in rats at high exposures; human data are insufficient. May cause fetal harm. Use only if benefit outweighs risk and inform the patient of the potential risk.
- Allattamento
- Unsafe No human milk data; present in rat milk. US label: do not breastfeed during treatment and for at least 2 weeks after the last dose; after a short pre-procedure course, pump and discard milk for that period.
Effetti indesiderati segnalati
- Pyrexia
- Abdominal pain
- Nausea
- Headache
- Fatigue
- Contusion
Controindicazioni
- None.
Chi deve prestare attenzione
- Thrombotic/thromboembolic complications: TPO receptor agonists are associated with thrombotic and thromboembolic events; monitor platelet counts and for signs of thromboembolism, and treat promptly.
- Consider increased thrombotic risk in patients with known risk factors, including genetic prothrombotic conditions and acquired factors such as antiphospholipid syndrome.
- Do not use to normalize platelet counts.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (12)
- Amiodarone + Avatrombopag Moderate
- Amobarbital + Avatrombopag Moderate
- Avatrombopag + Bosentan Moderate
- Avatrombopag + Carbamazepine Moderate
- Avatrombopag + Enzalutamide Moderate
- Avatrombopag + Fluconazole Moderate
- Avatrombopag + Ketoconazole Moderate
- Avatrombopag + Mifepristone Moderate
- Avatrombopag + Phenytoin Moderate
- Avatrombopag + Secobarbital Moderate
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Avatrombopag: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Avatrombopag used for?
Avatrombopag is a medicine in the class miscellaneous. It is used for Thrombocytopenia, Thrombocytopenic purpura.
What side effects have been reported with Avatrombopag?
Pyrexia, Abdominal pain, Nausea, Headache, Fatigue, Contusion.
Can Avatrombopag be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Animal studies showed miscarriage in rabbits and pup deaths in rats at high exposures; human data are insufficient. May cause fetal harm. Use only if benefit outweighs risk and inform the patient of the potential risk. Breastfeeding: Unsafe. No human milk data; present in rat milk. US label: do not breastfeed during treatment and for at least 2 weeks after the last dose; after a short pre-procedure course, pump and discard milk for that period.
What does Avatrombopag interact with?
MediHelp lists 12 known interactions for Avatrombopag. Moderate: 11 · Minor: 1. The most serious include Amiodarone, Amobarbital, Bosentan.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
